高级检索
当前位置: 首页 > 详情页

Anti-Ro52-positive antisynthetase syndrome (ASS): a case report and review of the literature

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]General Medicine, International Department of China-Japan Friendship Hospital, Beijing, China
出处:
ISSN:

关键词: Anti-Ro52 antibody antisynthetase syndrome (ASS) myositis-associated antibody interstitial lung disease case report

摘要:
Background: This study aimed to diagnose and treat a patient with anti-Ro52-positive antisynthetase syndrome (ASS), investigate the association between anti-Ro52 antibodies and ASS, and determine its clinical significance. The objective of this clinical report is to highlight this unusual syndrome to avoid incorrect diagnosis. Case Description: A middle-aged woman presenting with obvious lung symptoms was admitted to our hospital. A physical examination revealed swollen joints in both hands, mechanic's hands, and normal muscle strength and muscle tone in all 4 extremities. A myositis-specific antibody panel, lung computed tomographic (CT) imaging, electromyography, and muscle biopsy were performed as auxiliary examinations, and appropriate treatment was administered after the confirmed diagnosis. The myositis-specific antibody panel yielded strongly positive results for anti-Jo-1 and anti-Ro52 antibodies, lung CT imaging revealed interstitial lung disease, electromyography revealed myogenic damage, and muscle magnetic resonance imaging revealed multiple inflammatory exudates. A definitive diagnosis of ASS was made, and glucocorticoid and immunosuppressant therapy were administered. After treatment, the patient's symptoms were alleviated, creatine kinase activity was reduced, and signs of disease activity and secondary tumors were not observed on a subsequent follow-up evaluation. Conclusions: Anti-Ro52 antibodies, being myositis-associated antibodies, can lead to an atypical clinical presentation in ASS patients and are potentially associated with a poor prognosis. Therefore, thorough follow-up evaluation is required for such cases.

语种:
WOS:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 医学:研究与实验
最新[2025]版:
JCR分区:
出版当年[2020]版:
Q3 ONCOLOGY Q3 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2024]版:

影响因子: 最新[2024版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]General Medicine, International Department of China-Japan Friendship Hospital, Beijing, China
通讯作者:
通讯机构: [1]General Medicine, International Department of China-Japan Friendship Hospital, Beijing, China [*1]General Medicine, International Department of China-Japan Friendship Hospital, No. 2 Yinghua East Street, Chaoyang District, Beijing 100029, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:819 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)